Stock Titan Trading tools for traders and investors.

-

11:57:23 AM

Last PKI Stock Market News

PKI - Perkinelmer, Inc.

03/04/21 7:24 PM

NYSE : PKI

PerkinElmer Prices Offering of Senior Notes

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate

RHEA-AI

neutral

02/26/21 8:00 AM

NYSE : PKI

PerkinElmer to Present at Barclays Global Healthcare Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Barclays Global Healthcare Conference on Wednesday, March 10, 2021 from 9:45 a.m. to 10:10 a.m. ET.Prahlad Singh, president and chief executive

RHEA-AI

neutral

02/23/21 8:00 AM

NYSE : PKI

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening

PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer (R) COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow immunoassay test can be used to screen or to aid in

RHEA-AI

neutral

02/22/21 8:30 AM

NYSE : PKI

PerkinElmer Provides an Update on Valencia Branch Laboratory's Accreditation Process

PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory's (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department of Public Health (CDPH).

RHEA-AI

neutral

02/16/21 8:00 AM

NYSE : PKI

PerkinElmer to Present at Cowen Health Care Conference

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 41 st Annual Cowen Health Care Conference on Monday, March 1, 2021 from 12:20 p.m. to 12:50 p.m. ET.Prahlad Singh, president and chief executive

RHEA-AI

neutral

02/02/21 4:05 PM

NYSE : PKI

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 3, 2021.Fourth Quarter 2020The Company reported GAAP earnings per share from continuing operations of $3.38, as

RHEA-AI

neutral

01/28/21 4:15 PM

NYSE : PKI

PerkinElmer Board Declares Quarterly Dividend

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is payable on May 7, 2021 to all shareholders of record at the close of business on April 16, 2021.About PerkinElmerPerkinElmer, Inc.

RHEA-AI

neutral

01/14/21 8:00 AM

NYSE : PKI

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer (R) New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to test individuals without symptoms or other reasons to suspect COVID-19 infection.According

RHEA-AI

neutral

01/11/21 6:00 AM

NYSE : PKI

PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 2, 2021

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 66% and 63%, respectively, GAAP earnings per share from continuing operations of at least $2.88, and adjusted

RHEA-AI

neutral

01/07/21 7:00 AM

NYSE, Nasdaq : PKI, OXFD

PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer, Inc. (NYSE: PKI) (" PerkinElmer ") and Oxford Immunotec Global PLC (NASDAQ: OXFD) (" Oxford Immunotec" or the " Company ") are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the " Acquisition "). It is intended that

RHEA-AI

positive